XM does not provide services to residents of the United States of America.
S
S

Skanska

News

Skanska Expands Hospital In Oregon, US For $74 Mln

BRIEF-Skanska Expands Hospital In Oregon, US For $74 Mln July 15 (Reuters) - Skanska AB SKAb.ST : EXPANDS HOSPITAL IN ASTORIA, OREGON, USA FOR USD 74M, ABOUT SEK 780M Source text for Eikon: ID:nWkr72z7DZ Further company coverage: [SKAb.ST] (Gdansk Newsroom)
S

Skanska Rebuilds 7 Millbank In London For GBP 105 Mln

BRIEF-Skanska Rebuilds 7 Millbank In London For GBP 105 Mln July 15 (Reuters) - Skanska AB SKAb.ST : REBUILDS 7 MILLBANK IN LONDON, UK, FOR GBP 105M, ABOUT SEK 1.4 BILLION Source text for Eikon: ID:nWkr8kvDSN Further company coverage: [SKAb.ST] (Gdansk Newsroom)
S

Skanska Allocates Additional GBP 50 Mln On Works On Railway In UK

BRIEF-Skanska Allocates Additional GBP 50 Mln On Works On Railway In UK July 12 (Reuters) - Skanska AB SKAb.ST : SKANSKA ALLOCATED AN ADDITIONAL GBP 50M, ABOUT SEK 660M, TOWARDS WORKS ON THE HIGH-SPEED RAILWAY HS2 IN UK AS PART OF SKANSKA COSTAIN STRABAG JOINT VENTURE, HAS BEEN ALLOCATED AN ADDITIONAL GBP 50M UNDER EXISTING CONTRACT WITH HS2 LTD So
S

Skanska Rehabilitates And Modernizes Rail Tunnels In Northeast U.S

BRIEF-Skanska Rehabilitates And Modernizes Rail Tunnels In Northeast U.S July 12 (Reuters) - Skanska AB SKAb.ST : SKANSKA REHABILITATES AND MODERNIZES RAIL TUNNELS IN NORTHEAST UNITED STATES FOR USD 637M, ABOUT SEK 6.7 BILLION Source text for Eikon: ID:nWkr5NGmfg Further company coverage: [SKAb.ST] (Gdansk Newsroom)
S

Diageo, Publicis, Wolters Kluwer NV

EUROPE RESEARCH ROUNDUP-Diageo, Publicis, Wolters Kluwer NV July 11 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Diageo, Publicis and Wolters Kluwer NV, on Thursday. HIGHLIGHTS * Diageo DGE.L : HSBC cuts target price to 3,300p from 3,500p * Mfe-Mediaforeurope NV MFEB.MI : JP Morgan raises to overweight from neutral * Prosiebensat 1 Media SE PSMGn.DE : JP Morgan raises to overweight from neutral * Publicis PUBP.PA : JP Morgan cuts
A
A
A
B
C
C
D
D
D
D
E
E
G
H
K
L
P
R
S
S
V
A
A
A
A
B
D
G
J
W

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.